| Literature DB >> 30158228 |
Brian Køster1, Maria Kh Meyer1, Therese M-L Andersson2, Gerda Engholm3, Peter Dalum1.
Abstract
OBJECTIVE: To evaluate the effect of the Danish Sun Safety Campaign 2007-2015 on the prevalence of sunbed use and to model future effects on the skin cancer incidences 2007-2040.Entities:
Keywords: campaign; prevention; skin cancer; ultraviolet radiation
Mesh:
Year: 2018 PMID: 30158228 PMCID: PMC6119446 DOI: 10.1136/bmjopen-2018-022094
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Distribution of demographic characteristics in cross-sectional surveys on ultraviolet exposure 2007–2015 of 37 766 Danes
| Characteristic | Total (n) | % or mean | March | August | August | August | August | August | August | August | August | August |
| Total (n) | 37 766 |
| 4303 | 4451 | 4277 | 4186 | 4156 | 4130 | 2195 | 4022 | 2047 | 3999 |
|
| P< | |||||||||||
| Male | 18 437 |
| 44 | 44 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
| Female | 19 300 |
| 56 | 56 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
|
| P< | |||||||||||
| 15–19 | 3417 |
| 8 | 8 | 10 | 9 | 10 | 9 | 9 | 10 | 10 | 10 |
| 20–29 | 6017 |
| 9 | 8 | 18 | 17 | 17 | 17 | 17 | 19 | 19 | 20 |
| 30–39 | 7409 |
| 20 | 20 | 16 | 21 | 21 | 21 | 21 | 19 | 19 | 18 |
| 40–49 | 8442 |
| 21 | 23 | 23 | 22 | 22 | 22 | 22 | 23 | 22 | 22 |
| 50–59 | 7547 |
| 20 | 19 | 24 | 20 | 20 | 20 | 20 | 19 | 18 | 18 |
| 60–64 | 3933 |
| 11 | 10 | 8 | 11 | 10 | 10 | 10 | 11 | 12 | 12 |
| missing | 1001 |
| 11 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| P< | |||||||||||
| I | 4550 |
| 12 | 10 | 11 | 10 | 10 | 11 | 11 | 16 | 15 | 15 |
| II | 19 316 |
| 51 | 51 | 52 | 52 | 53 | 54 | 51 | 48 | 50 | 50 |
| III | 12 203 |
| 34 | 35 | 33 | 34 | 34 | 32 | 33 | 29 | 31 | 28 |
| IV–VI | 735 |
| 3 | 3 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
| missing | 962 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| P< | |||||||||||
| Capital | 13 065 |
| 39 | 46 | 33 | 32 | 32 | 32 | 31 | 32 | 32 | 32 |
| Zealand | 4680 |
| 11 | 9 | 13 | 12 | 12 | 12 | 15 | 14 | 14 | 14 |
| Northern Jutland | 7028 |
| 10 | 9 | 10 | 11 | 10 | 10 | 10 | 10 | 10 | 10 |
| Central Jutland | 8086 |
| 21 | 18 | 21 | 22 | 21 | 22 | 23 | 23 | 21 | 23 |
| Southern Denmark | 3749 |
| 16 | 14 | 18 | 18 | 19 | 18 | 22 | 21 | 23 | 21 |
| Missing | 1158 |
| 3 | 3 | 5 | 5 | 6 | 5 | 0 | 0 | 0 | 0 |
|
| P< | |||||||||||
| <10 years | 9372 |
| 18 | 16 | 31 | 32 | 28 | 29 | 28 | 28 | 8 | 24 |
| 10–12 years | 14 881 |
| 29 | 28 | 44 | 45 | 49 | 49 | 42 | 40 | 27 | 42 |
| >12 years | 12 909 |
| 54 | 55 | 25 | 22 | 22 | 21 | 28 | 31 | 64 | 32 |
| Missing/unspecified | 604 |
| 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 |
|
| P< | |||||||||||
| Yes | 24 350 |
| 72 | 61 | 65 | 67 | 65 | 61 | 60 | 64 | 66 | 63 |
| No | 13 416 |
| 28 | 39 | 35 | 33 | 35 | 39 | 40 | 36 | 34 | 37 |
|
| P< | |||||||||||
| Yes | 12 527 |
| 35 | 36 | 32 | 33 | 33 | 34 | 25 | 34 | 34 | 32 |
| No | 25 239 |
| 65 | 64 | 68 | 67 | 67 | 66 | 75 | 66 | 66 | 68 |
|
| P< |
| 17.4 | 15.9 | 16.3 | 15.6 | 16.3 | 15.8 | 14.3 | 15.7 | 17.2 | 14.1 |
|
| P< |
| 285 | 197 | 281 | 250 | 248 | 212 | 203 | 254 | 274 | 210 |
|
| P< |
| 8.5 | 18 | 13.5 | 15.2 | 11.9 | 15.6 | 19.4 | 12.3 | 13.3 | 16.2 |
Bold type emphasise variable headings and average.
P values are for χ2 test between factor levels and year of measurement. Values are percentage except for weather variables, which are expressed as means.
Figure 1Illustration of data projections and scenarios. MM, malignant melanoma.
Figure 2(A) Values are OR (95% CI) sunbed use (recent use) compared with 2007 precampaign measurement adjusted for gender, age, education, region and skin type. (B) Values are OR (95% CI) sunbed use (ever use) compared with the 2007 precampaign measurement adjusted for gender, age, education, region and skin type.
Logistic regression analysis of sunbed use (ever use) in Denmark 2007–2015 by demographic factors and annual percentage decrease in sunbed use overall and by factor levels
| Characteristic | Total (n) | % or mean | Crude OR (95% CI) | Adjusted OR (95% CI)* | Adjusted OR (95% CI)† | Sunbed use annual change | Sunbed use annual change (adjusted) |
| Total (n) | 37 562 | 18 | 34 616 | 34 616 | 34 616 | 0.97 (0.97–0.97) |
|
|
| P< | P< | P< | ||||
| Male | 18 325 | 13 | 1 (ref) | 1 (ref) | 1 (ref) | 0.99 (0.98–1.00) | |
| Female | 19 237 | 22 | 2.78 (2.66 to 2.90) | 3.02 (2.88 to 3.16) | 2.66 (2.53 to 2.79) | 0.95 (0.95–0.96) | |
|
| P< | P< | P< | ||||
| 15–19 | 3383 | 27 | 1.38 (1.25 to 1.53) | 1.30 (1.17 to 1.44) | 1.03 (0.92 to 1.15) | 0.91 (0.90–0.92) | |
| 20–29 | 5970 | 25 | 3.22 (2.95 to 3.51) | 3.28 (2.99 to 3.61) | 3.06 (2.78 to 3.37) | 0.90 (0.89–0.91) | |
| 30–39 | 7369 | 19 | 4.37 (4.01 to 4.76) | 4.53 (4.11 to 4.98) | 4.78 (4.33 to 5.28) | 0.94 (0.93–0.96) | |
| 40–49 | 8419 | 18 | 2.97 (2.74 to 3.23) | 3.01 (2.75 to 3.30) | 2.95 (2.69 to 3.24) | 1.00 (0.99–1.01) | |
| 50–59 | 7529 | 12 | 1.49 (1.37 to 1.62) | 1.48 (1.36 to 1.62) | 1.45 (1.32 to 1.58) | 1.00 (0.99–1.00) | |
| 60–64 | 3922 | 8 | 1 (ref) | 1 (ref) | 1 (ref) | 0.99 (0.97–1.00) | |
|
| P< | P< | P< | ||||
| I | 4534 | 13 | 1.08 (0.92 to 1.28) | 0.64 (0.54 to 0.76) | 0.80 (0.66 to 0.95) | 0.97 (0.96–0.98) | |
| II | 19 252 | 18 | 1.19 (1.02 to 1.36) | 0.92 (0.78 to 1.09) | 0.99 (0.83 to 1.17) | 0.97 (0.97–0.97) | |
| III | 12 141 | 19 | 0.96 (0.82 to 1.13) | 0.90 (0.76 to 1.07) | 0.93 (0.78 to 1.10) | 0.98 (0.96–0.98) | |
| IV–VI | 733 | 23 | 1 (ref) | 1 (ref) | 1 (ref) | 0.98 (0.95–1.00) | |
|
| P< | P< | P< | ||||
| Capital | 12 998 | 15 | 1 (ref) | 1 (ref) | 1 (ref) | 0.97 (0.97–0.98) | |
| Zealand | 4652 | 16 | 0.88 (0.82 to 0.97) | 1.15 (1.04 to 1.27) | 0.99 (0.92 to 1.07) | 0.98 (0.96–0.99) | |
| Northern Jutland | 3730 | 21 | 1.17 (1.08 to 1.26) | 0.93 (0.87 to 1.01) | 1.30 (1.20 to 1.42) | 0.97 (0.96–0.98) | |
| Central Jutland | 8042 | 19 | 1.08 (1.02 to 1.14) | 1.15 (1.08 to 1.22) | 1.18 (1.10 to 1.25) | 0.96 (0.95–0.97) | |
| Southern Denmark | 6985 | 18 | 0.99 (0.94 to 1.06) | 1.08 (1.01 to 1.15) | 1.11 (1.04 to 1.19) | 0.97 (0.97–0.98) | |
|
| P< | P< | P< | ||||
| <10 years | 9313 | 17 | 0.64 (0.61 to 0.68) | 1.01 (0.94 to 1.07) | 1.10 (1.03 to 1.17) | 0.97 (0.96–0.98) | |
| 10–12 years | 7130 | 20 | 1.04 (0.99 to 1.09) | 1.12 (1.06 to 1.19) | 1.16 (1.10 to 1.22) | 0.95 (0.95–0.96) | |
| >12 years | 7682 | 18 | 1 (ref) | 1 (ref) | 1 (ref) | 0.98 (0.98–0.99) | |
|
| P< | NA | P< | ||||
| Yes | 24 240 | 24 | 4.16 (3.85 to 4.49) | 2.73 (2.59 to 2.87) | 0.96 (0.96–0.97) | ||
| No | 13 322 | 7 | 1 (ref) | 1 (ref) | 0.99 (0.99–1.00) | ||
|
| N | P= | P= | ||||
| Yes | 12 461 | 18 | 1.55 (1.49 to 1.63) | 1.06 (1.01 to 1.12) | 1.05 (0.99 to 1.11) | 0.96 (0.96–0.97) | |
| No | 25 101 | 17 | 1 (ref) | 1 (ref) | 1 (ref) | 0.98 (0.97–0.98) | |
|
| P< | NA | P< | ||||
| 1.11 (1.08 to 1.13) | 1.15 (1.11 to 1.19) | ||||||
|
| P< | NA | P= | ||||
| 1.13 (1.08 to 1.19) | 1.23 (1.07 to 1.42) | ||||||
|
| P< | NA | P< | ||||
| 0.99 (0.98 to 0.99) | 1.04 (1.03 to 1.06) |
ORs and CIs
*Model adjusted for gender, age, education, skin type, have children and region.
†Model additionally adjusted for sunbathing and weather indicators.
NA, not applicable.
Figure 3(A) The expected number of malignant melanoma (MM) cases, when sunbed use is unchanged; there is a reversible or irreversible campaign effect. Assumed estimated annual percentage change 2007–2022 (4% increase) and 2022–2040 (0% constant). LAT time of 2 years and LAG time of 5 years. (B) The expected number of SCC cases, when sunbed use is unchanged; there is a reversible or irreversible campaign effect. Assumed estimated annual percentage change 2007–2022 (4% increase) and 2022–2040 (0% constant). LAT time of 2 years and LAG time of 8 years. (C) The expected number of BCC cases, when sunbed use is unchanged; there is a reversible or irreversible campaign effect. Assumed estimated annual percentage change 2007–2022 (4% increase) and 2022–2040 (0% constant). LAT time of 2 years and LAG time of 8 years.
Projected change in number of skin cancer cases 2007–2040 based on modelled scenarios of the change in sunbed use fraction 2007–2015 in Denmark compared with trend
| Projections based on campaign results 2007–2015 | Sensitivity variations of scenario 2 | |||||
| Scenario | 1 (irreversible) | 2 (reversible) | *EAPC0 | *EAPC30 | †LATLAG, 0 | †LATLAG, double |
| Total MM cases | 111.353 | 111.353 | 63.104 | 154.525 | 111.353 | 111.353 |
| Total SCC cases | 136.999 | 136.999 | 83.108 | 184.766 | 136.999 | 136.999 |
| Total BCC cases | 414.817 | 414.817 | 254.859 | 547.749 | 414.817 | 414.817 |
| ΔTotal MM | 2.443 (2.2 %) | 746 (0.7 %) | 423 (0.7 %) | 800 (0.5 %) | 584 (0.5 %) | 869 (0.8 %) |
| ΔTotal SCC | 5.383 (3.9 %) | 1.562 (1.1 %) | 945 (1.1 %) | 1.705 (0.9 %) | 1.220 (0.9 %) | 1.885 (1.4 %) |
| ΔTotal BCC | 8.437 (2.0 %) | 2.673 (0.6 %) | 1.623 (0.6 %) | 2.898 (0.5 %) | 2.107 (0.5 %) | 3.131 (0.8 %) |
*EAPC0 and EAPC30 correspond to number of years with the estimated annual percentage change (EAPC = 4 %) in incidence. The remaining years are constant, ie, EAPC = 0 %. The main scenarios apply 15 years the indicated EAPC.
†LATLAG, 0 and double, respectively, is the time from an intervention is applied to the effect of the intervention on the risk factor affects the risk of cancer.
MM, malignant melanoma.